JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB218535

Anti-LYVE1 antibody [EPR21771]

1

(1 Review)

|

(21 Publications)

Anti-LYVE1 antibody [EPR21771] (ab218535) is a rabbit monoclonal antibody detecting LYVE1 in Western Blot, Flow Cytometry, IP, IHC-P, IHC-Fr. Suitable for Mouse.

- Biophysical QC for unrivalled batch-batch consistency

View Alternative Names

Crsbp1, Xlkd1, Lyve1, Lymphatic vessel endothelial hyaluronic acid receptor 1, LYVE-1, Cell surface retention sequence-binding protein 1, Extracellular link domain-containing protein 1, CRSBP-1

9 Images
Flow Cytometry - Anti-LYVE1 antibody [EPR21771] (AB218535)
  • Flow Cyt

Lab

Flow Cytometry - Anti-LYVE1 antibody [EPR21771] (AB218535)

Flow cytometry overlay histogram showing left, bEND.3 treated with 100ng/mL TNF-alpha for 24h and right, negative untreated bEND.3 stained with ab218535 (red line). The cells were incubated in 1x PBS containing 10% normal goat serum to block non-specific protein-protein interactionfollowed by the antibody (ab218535) (1x 106 in 100μl at 10.0 μg/ml (1/209)) for 30min on ice.

The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min on ice

Isotype control antibody (black line) was Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control used at the same concentration and conditions as the primary antibody. Unlabelled sample (blue line) was also used as a control.

Acquisition of >5000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LYVE1 antibody [EPR21771] (AB218535)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LYVE1 antibody [EPR21771] (AB218535)

Immunohistochemical analysis of paraffin-embedded mouse liver tissue labeling LYVE1 with ab218535 at 1/5000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Positive staining on the endothelial surface of mouse hepatic sinusoids (PMID : 16353487; PMID : 11719431). Counter stained with Hematoxylin. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Immunohistochemistry (Frozen sections) - Anti-LYVE1 antibody [EPR21771] (AB218535)
  • IHC-Fr

Supplier Data

Immunohistochemistry (Frozen sections) - Anti-LYVE1 antibody [EPR21771] (AB218535)

Immunohistochemical analysis of 4% paraformaldehyde-fixed, 0.2% Triton X-100 permeabilized frozen mouse liver tissue labeling LYVE1 with ab218535 at 1/500 dilution (green), followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Positive staining of the endothelium of sinusoid blood vessels on mouse liver tissue section (PMID : 11719431).

The nuclear counter stain is DAPI (blue).

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.

Flow Cytometry - Anti-LYVE1 antibody [EPR21771] (AB218535)
  • Flow Cyt

Supplier Data

Flow Cytometry - Anti-LYVE1 antibody [EPR21771] (AB218535)

Flow cytometric analysis of bEnd.3 (mouse brain endothelioma cell line) cells labeling LYVE1 with ab218535 at 1/60 dilution (red) compared with a Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) at 1/2000 dilution was used as the secondary antibody.

Gated on total viable cells.

Immunohistochemistry (Frozen sections) - Anti-LYVE1 antibody [EPR21771] (AB218535)
  • IHC-Fr

Supplier Data

Immunohistochemistry (Frozen sections) - Anti-LYVE1 antibody [EPR21771] (AB218535)

Immunohistochemical analysis of 4% paraformaldehyde-fixed, 0.2% Triton X-100 permeabilized frozen mouse stomach tissue labeling LYVE1 with ab218535 at 1/5000 dilution (green), followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Positive staining of the endothelium of lymph vessels in the submucosae on mouse stomach tissue section (PMID : 15705793).

The nuclear counter stain is DAPI (blue).

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LYVE1 antibody [EPR21771] (AB218535)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LYVE1 antibody [EPR21771] (AB218535)

Immunohistochemical analysis of paraffin-embedded mouse lung tissue labeling LYVE1 with ab218535 at 1/2000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Positive staining on the lymphatic endothelial cells of mouse lung is observed. Counter stained with hematoxylin. Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LYVE1 antibody [EPR21771] (AB218535)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LYVE1 antibody [EPR21771] (AB218535)

Immunohistochemical analysis of paraffin-embedded mouse colon tissue labeling LYVE1 with ab218535 at 1/5000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Positive staining on the lymphatic endothelium of mouse colon (PMID : 14722766). Counter stained with Hematoxylin. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Immunoprecipitation - Anti-LYVE1 antibody [EPR21771] (AB218535)
  • IP

Supplier Data

Immunoprecipitation - Anti-LYVE1 antibody [EPR21771] (AB218535)

LYVE1 was immunoprecipitated from 0.35 mg mouse lung lysate with ab218535 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab218535 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/5000 dilution.

Lane 1 : Mouse lung lysate 10 μg (Input).

Lane 2 : ab218535 IP in mouse lung lysate.

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab218535 in mouse lung lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 8 seconds.

Several bands are observed including soluble, glycosylated and non-glycosylated forms which are consistent with the literature (PMID : 26966180).

All lanes:

Immunoprecipitation - Anti-LYVE1 antibody [EPR21771] (ab218535)

Predicted band size: 35 kDa

false

Western blot - Anti-LYVE1 antibody [EPR21771] (AB218535)
  • WB

Supplier Data

Western blot - Anti-LYVE1 antibody [EPR21771] (AB218535)

Exposure time : Lane 1 : 3 minutes; Lane 2 : 32 seconds; Lane 3 : 5 seconds.

Blocking/Dilution buffer : 5% NFDM/TBST.

Several bands are observed including soluble, glycosylated and non-glycosylated forms which are consistent with the literature (PMID : 26966180).

All lanes:

Western blot - Anti-LYVE1 antibody [EPR21771] (ab218535) at 1/1000 dilution

Lane 1:

Mouse lymph node lysate at 20 µg

Lane 2:

bEnd.3 (mouse brain endothelioma cell line) whole cell lysate at 20 µg

Lane 3:

Mouse lung lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/10000 dilution

Predicted band size: 35 kDa

Observed band size: 34-70 kDa

true

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-LYVE1 antibody [EPR21771]

  • 660 APC

    APC Anti-LYVE1 antibody [EPR21771]

  • Carrier free

    Anti-LYVE1 antibody [EPR21771] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR21771

Isotype

IgG

Carrier free

No

Reacts with

Mouse

Applications

WB, IHC-Fr, IP, Flow Cyt, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCFr" : {"fullname" : "Immunohistochemistry (Frozen sections)", "shortname":"IHC-Fr"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/60", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCFr-species-checked": "testedAndGuaranteed", "IHCFr-species-dilution-info": "1/500", "IHCFr-species-notes": "<p>Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/5000", "IHCP-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-LYVE1 antibody [EPR21771] (ab218535) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunohistochemistry (IHC-Fr) in Mouse samples.

What is the molecular weight of LYVE1?
Anti-LYVE1 [EPR21771] (ab218535) specifically detects a band for LYVE1 (UniProt: Q8BHC0) at a molecular weight of 35kDa.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Other related products
We have a range of other formats of antibody clone [EPR21771] also available for your convenience: ab218535, Carrier free - ab230377, Alexa Fluor® 647 - ab252162, APC - ab252163

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The protein "LYVE1" also known as Lymphatic Vessel Endothelial Hyaluronan Receptor 1 has a molecular mass of about 60 kDa. This protein is located on the surface of lymphatic endothelial cells. Its expression occurs mainly within the lymphatic vessels serving as an important marker for identifying lymphatic endothelium. LYVE1 facilitates the transportation of hyaluronan an important glycosaminoglycan through lymphatic vessels playing a critical role in the maintenance of extracellular matrix and tissue fluid homeostasis.
Biological function summary

LYVE1 plays a role in lymphatic system regulation and immune cell trafficking. It forms part of a network that binds hyaluronan contributing to the regulation of cell migration and adhesion. This protein interacts with molecules like CD44 and other receptors which also participate in hyaluronan binding. LYVE1's function in maintaining the balance of hyaluronan within tissues is central affecting not only the lymphatic system but also immune responses.

Pathways

LYVE1 engages in both the hyaluronan metabolism and lymphangiogenesis pathways. Its interaction with CD44 plays a significant role in the transport and uptake of hyaluronan influencing cellular processes such as proliferation and motility. These interactions link LYVE1 to pathways controlling fluid balance and immune surveillance marking it as essential for maintaining healthy lymphatic and immune function.

LYVE1 shows a connection to lymphatic-related conditions such as lymphedema and cancer metastasis. Alterations or dysregulation of LYVE1 expression can affect lymphatic function potentially leading to the accumulation of interstitial fluid as seen in lymphedema. In cancer increased LYVE1 expression can relate to tumor metastasis where it functions alongside proteins like VEGFR-3 in promoting lymphatic vessel growth and facilitating cancer cell spread.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Ligand-specific transporter trafficking between intracellular organelles (TGN) and the plasma membrane. Plays a role in autocrine regulation of cell growth mediated by growth regulators containing cell surface retention sequence binding (CRS). May act as a hyaluronan (HA) transporter, either mediating its uptake for catabolism within lymphatic endothelial cells themselves, or its transport into the lumen of afferent lymphatic vessels for subsequent re-uptake and degradation in lymph nodes (PubMed : 10187853). Binds to pericelluar hyaluronan matrices deposited on the surface of leukocytes and facilitates cell adhesion and migration through lymphatic endothelium (By similarity).
See full target information Lyve1

Publications (21)

Recent publications for all applications. Explore the full list and refine your search

International journal of medical sciences 22:3839-3853 PubMed41049446

2025

PRDX3 Promotes Lymph Node Metastasis in Cervical Cancer by Activating NF-κB Signaling Pathway and Anoikis Resistance.

Applications

Unspecified application

Species

Unspecified reactive species

Weijia Wen,Jiaying Li,Li Yuan,Yan Liao,Caixia Shao,Dingze Xu,Hongye Jiang,Yuandong Liao,Pan Liu,Chunyu Zhang,Shuzhong Yao,Wei Wang

Theranostics 15:9580-9600 PubMed41041054

2025

Macrophage-TREM2 promotes cardiac repair by restricting the infiltration of CD8 T cells via CXCL16-CXCR6 axis after myocardial infarction.

Applications

Unspecified application

Species

Unspecified reactive species

Linlin Zhang,Sheng Wang,Yu Ding,Tao Zheng,Jie Sheng,Yanshan Chen,Zhiyue Wang,Ximei Dai,Canbiao Wang,Long Ma,Jing Pan,Yunming Zhang,Longjiang Zhang

Journal of cell communication and signaling 19:e70025 PubMed40520075

2025

Adipose-derived stem cell exosomes alleviate TGF-β1-induced urethral stricture fibrosis by suppressing the TGF-β/Smad pathway and downstream PDGFR-β/RAS/ERK signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Tao Liang,Chao Deng,Hang Guo,Zhenghao Dai,Yiwen Jiang,Yuting Lu,Weiguo Chen

BMC oral health 25:678 PubMed40316997

2025

Macrophage is crucial for tongue development by regulating myogenesis and vascularization.

Applications

Unspecified application

Species

Unspecified reactive species

Ziyao Wang,Mengqiao Wang,Jiani Liu,Delu Zhao,Jixiao Wang,Fulan Wei

Molecular carcinogenesis 64:1039-1056 PubMed40135589

2025

SOAT1 Activates NLRP3 Inflammasome to Promote Cancer-Related Lymphangiogenesis and Metastasis via IL-1β/IL-1R-1 Axis in Oral Squamous Cell Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Chengzhi Zhao,Yuhao Wang,Zhishen Jiang,Shengzhao Guo,Liru Hu,Jian Pan,Fan Dan

PloS one 20:e0312587 PubMed39752388

2025

CD206+ Trem2+ macrophage accumulation in the murine knee joint after injury is associated with protection against post-traumatic osteoarthritis in MRL/MpJ mice.

Applications

Unspecified application

Species

Unspecified reactive species

Jillian L McCool,Aimy Sebastian,Nicholas R Hum,Stephen P Wilson,Oscar A Davalos,Deepa K Murugesh,Beheshta Amiri,Cesar Morfin,Blaine A Christiansen,Gabriela G Loots

The breast journal 2024:7813083 PubMed39742358

2025

Inhibition of Lymphangiogenesis: A Protective Role of microRNA 146a-5p in Breast Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Wenlong Liang,Haoran Wang,Baiyang Fu,Yuan Song,Zheng Zhang,Xin Liu,Yujia Lin,Jianguo Zhang

Cells 13: PubMed39594584

2024

Modeling Lymphoma Angiogenesis, Lymphangiogenesis, and Vessel Co-Option, and the Effects of Inhibition of Lymphoma-Vessel Interactions with an αCD20-EndoP125A Antibody Fusion Protein.

Applications

Unspecified application

Species

Unspecified reactive species

Christian Elledge,Yu Zhang,Seung-Uon Shin,Hyun-Mi Cho,Sundaram Ramakrishnan,Ankita Sankar,Jennifer R Chapman,Daniel Bilbao,Rathin Das,Hava Gil-Henn,Izidore S Lossos,Joseph D Rosenblatt

Nature communications 15:8303 PubMed39333107

2024

SOLID: minimizing tissue distortion for brain-wide profiling of diverse architectures.

Applications

Unspecified application

Species

Unspecified reactive species

Jingtan Zhu,Xiaomei Liu,Zhang Liu,Yating Deng,Jianyi Xu,Kunxing Liu,Ruiying Zhang,Xizhi Meng,Peng Fei,Tingting Yu,Dan Zhu

Nature 634:457-465 PubMed39231480

2024

Early intermittent hyperlipidaemia alters tissue macrophages to fuel atherosclerosis.

Applications

Unspecified application

Species

Unspecified reactive species

Minoru Takaoka,Xiaohui Zhao,Hwee Ying Lim,Costan G Magnussen,Owen Ang,Nadine Suffee,Patricia R Schrank,Wei Siong Ong,Dimitrios Tsiantoulas,Felix Sommer,Sarajo K Mohanta,James Harrison,Yaxing Meng,Ludivine Laurans,Feitong Wu,Yuning Lu,Leanne Masters,Stephen A Newland,Laura Denti,Mingyang Hong,Mouna Chajadine,Markus Juonala,Juhani S Koskinen,Mika Kähönen,Katja Pahkala,Suvi P Rovio,Juha Mykkänen,Russell Thomson,Tsuneyasu Kaisho,Andreas J R Habenicht,Marc Clement,Alain Tedgui,Hafid Ait-Oufella,Tian X Zhao,Meritxell Nus,Christiana Ruhrberg,Soraya Taleb,Jesse W Williams,Olli T Raitakari,Véronique Angeli,Ziad Mallat
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com